Safety Shot Responds To FSD Pharma's Unauthorized Tagging Of Its Stock And Making False Claims In An Effort To Harm The Company And Its Shareholders
Portfolio Pulse from Benzinga Newsdesk
Safety Shot, Inc. (SHOT) clarifies that it has only acquired the Safety Shot beverage asset, not GBB Drink Lab, Inc. (GBB), contrary to FSD Pharma's claims. A federal court has refused to dismiss GBB's lawsuit against FSD Pharma for violating an NDA and allegedly attempting to steal and launch GBB's product. Safety Shot continues its national launch of a wellness beverage. FSD Pharma has been tagging SHOT's stock ticker in communications, which Safety Shot claims is an attempt to harm the company and its shareholders.
January 17, 2024 | 1:11 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Safety Shot, Inc. is involved in a legal dispute with FSD Pharma, which has been tagging SHOT's ticker in a potentially harmful manner. The company continues its product launch despite these challenges.
While the legal dispute and false claims by FSD Pharma could create uncertainty, the court's refusal to dismiss GBB's lawsuit and the ongoing product launch may balance the sentiment. The impact on SHOT's stock price is uncertain in the short term, hence a neutral score.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80